FDA Inspection 1147428 - Enemeez, LLC dba Summit Pharmaceuticals - July 29, 2021

Record Details

This FDA Inspection record concerns Enemeez, LLC dba Summit Pharmaceuticals, with an inspection on July 29, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Enemeez, LLC dba Summit Pharmaceuticals
Inspection Date: July 29, 2021
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 7e7bbba6-611e-4478-a3de-f582c1b59bd4

Violation Codes3

21 CFR 211.166(a)21 CFR 211.166(a)(2)21 CFR 211.166(a)(3)

Full citation text and observation details available on the Dashboard.